Radiographic progression-free survival in the ACIS trial for prostate cancer reply

被引：0
|
作者：
Saad, Fred [1 ]
De Porre, Peter [2 ]
Brookman-May, Sabine [3 ,4 ]
Li, Jinhui [5 ]
McCarthy, Sharon A. [6 ]
Rathkopf, Dana E. [7 ,8 ]
机构：
[1] Univ Montreal, Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[2] Janssen Res & Dev, Beerse, Belgium
[3] Janssen Res & Dev, Los Angeles, CA USA
[4] Ludwig Maximilians Univ Munchen, Munich, Germany
[5] Janssen Res & Dev, San Diego, CA USA
[6] Janssen Res & Dev, Raritan, NJ USA
[7] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[8] Weill Cornell Med, New York, NY USA
来源：
LANCET ONCOLOGY | 2022年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E5 / E6
页数：2
相关论文
共 50 条
  • [41] Evolutionary Approaches to Prolong Progression-Free Survival in Breast Cancer
    Silva, Ariosto S.
    Kam, Yoonseok
    Khin, Zayar P.
    Minton, Susan E.
    Gillies, Robert J.
    Gatenby, Robert A.
    CANCER RESEARCH, 2012, 72 (24) : 6362 - 6370
  • [42] Oxaliplatin improves progression-free survival in patients with colorectal cancer
    不详
    ONCOLOGY-NEW YORK, 2001, 15 (01): : 83 - 83
  • [43] Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone Acetate
    Attard, Gerhardt
    de Bono, Johann S.
    Logothetis, Christopher J.
    Fizazi, Karim
    Mukherjee, Som D.
    Joshuas, Anthony M.
    Schrijvers, Dirk
    van den Eertwegh, Alfons J. M.
    Li, Weimin
    Molina, Arturo
    Griffin, Thomas W.
    Kheoh, Thian
    Ricci, Deborah S.
    Zelinsky, Kathy
    Rathkopf, Dana E.
    Scher, Howard I.
    Ryan, Charles J.
    CLINICAL CANCER RESEARCH, 2015, 21 (07) : 1621 - 1627
  • [44] ELACESTRANT PROLONGS PROGRESSION-FREE SURVIVAL IN ADVANCED BREAST CANCER
    不详
    CANCER DISCOVERY, 2022, 12 (07) : 1609 - 1609
  • [45] Progression-free survival benefits in triple negative breast cancer
    Fricker, Janet
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (11) : 610 - 610
  • [46] Progression-Free Survival Remains Debatable Endpoint in Cancer Trials
    Tuma, Rabiya
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (21) : 1439 - 1441
  • [47] A Nomogram for Predicting Progression-free Survival in Patients with Endometrial Cancer
    Wang, Z.
    Zhao, Z.
    Li, W.
    Bao, X.
    Liu, T.
    Yang, X.
    CLINICAL ONCOLOGY, 2023, 35 (09) : e516 - e527
  • [48] Inappropriate use of progression-free survival in cancer drug approvals
    Naci, Huseyin
    Davis, Courtney
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 368
  • [49] NEJ026 trial: progression-free survival benefit is not enough
    Liang, Fei
    LANCET ONCOLOGY, 2019, 20 (07): : E344 - E344
  • [50] CORRECT trial: regorafenib significantly increases overall and progression-free survival
    不详
    COLORECTAL CANCER, 2012, 1 (04) : 283 - 283
12345